Drug recall · August 19, 2015
Methotrexate Injection recall
Why: Presence of Particulate Matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.
- Lots / codes
Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16
- Quantity
- a) 15,095 vials b) 300 vials
- Company
- Mylan Institutional LLC, Rockford, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- March 18, 2015 · Voluntary: Firm initiated
- Classified
- August 13, 2015
- Reported
- August 19, 2015
- Ended
- June 29, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methotrexate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.